US Stock MarketDetailed Quotes
KURA Kura Oncology
- 10.060
- -5.850-36.77%
Close Nov 21 16:00 ET
- 10.090
- +0.030+0.30%
Post 20:01 ET
782.30MMarket Cap-4280P/E (TTM)
12.240High9.680Low17.54MVolume11.800Open15.910Pre Close182.00MTurnover32.53%Turnover RatioLossP/E (Static)77.76MShares24.17052wk High1.85P/B542.46MFloat Cap9.06052wk Low--Dividend TTM53.92MShs Float43.000Historical High--Div YieldTTM16.09%Amplitude2.500Historical Low10.376Avg Price1Lot Size
About Kura Oncology Company
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.
Company Profile
SymbolKURA
Company NameKura Oncology
Listing DateNov 5, 2015
Issue Price16.00
Founded2014
CEODr. Troy E. Wilson, PhD, J.D.
MarketNASDAQ
Employees142
Fiscal Year Ends12-31
Address12730 High Bluff Drive,Suite 400
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-500-8800
Websitehttp://www.kuraoncology.com
Company Executives
- Name
- Position
- Salary
- Dr. Troy E. Wilson, PhD, J.D.
- Chairman of the Board, President and Chief Executive Officer
- 5.25M
- Teresa Brophy Bair, Esq.
- Chief Legal Officer and Secretary
- 1.98M
- Kathleen Ford
- Chief Operating Officer
- 2.16M
- Stephen Dale
- Chief Medical Officer
- 2.47M
- Brian T. Powl
- Chief Commercial Officer
- --
- Thomas Doyle
- Senior Vice President, Finance and Accounting and Principal Accounting Officer
- --
- Dr. Michael J. Vasconcelles, M.D.
- Director
- --
- Mary T. Szela
- Independent Director
- 279.80K
- Dr. Helen Collins, M.D.
- Independent Director
- 265.81K
- Carol A. Schafer
- Independent Director
- 279.05K
- Faheem Hasnain
- Lead Independent Director
- 300.54K
- Diane L. Parks, M.B.A.
- Independent Director
- 268.49K
- Thomas R. Malley
- Independent Director
- 275.69K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data